Other OTC Pharmaceuticals (Pharmacies) - Mozambique

  • Mozambique
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$15.23m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.43%, resulting in a market volume of US$18.03m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.44 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Mozambique has been experiencing significant growth in recent years.

Customer preferences:
Customers in Mozambique have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of these products. OTC pharmaceuticals are readily available in pharmacies and do not require a prescription, making them easily accessible to consumers. Additionally, OTC products are often more affordable compared to prescription medications, making them a popular choice for individuals seeking self-care solutions.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Mozambique is the increasing demand for preventive healthcare products. With a growing awareness of the importance of maintaining good health, consumers are actively seeking OTC products that can help prevent common illnesses and promote overall well-being. This trend is reflected in the rising sales of vitamins, supplements, and other preventive healthcare products in pharmacies across the country. Another trend in the market is the growing popularity of natural and herbal remedies. Consumers are increasingly turning to alternative medicine and natural remedies for various health concerns. This shift can be attributed to a desire for more holistic and organic solutions, as well as a growing mistrust of synthetic pharmaceuticals. As a result, pharmacies are expanding their offerings to include a wider range of natural and herbal products to cater to this demand.

Local special circumstances:
Mozambique is a country with a high burden of infectious diseases, such as malaria and HIV/AIDS. This has a significant impact on the Other OTC Pharmaceuticals (Pharmacies) market, as consumers often seek OTC products to manage and treat these conditions. Pharmacies play a crucial role in providing access to essential medications for these diseases, as well as offering guidance and support to patients. Additionally, the lack of healthcare infrastructure in rural areas of Mozambique further emphasizes the importance of pharmacies in the country. Many rural communities do not have access to healthcare facilities or doctors, making pharmacies the primary source of healthcare for these populations. As a result, pharmacies in these areas often stock a wider range of OTC products to meet the diverse healthcare needs of the community.

Underlying macroeconomic factors:
The growing middle class in Mozambique is a key driver of the Other OTC Pharmaceuticals (Pharmacies) market. As disposable incomes increase, consumers have more purchasing power to spend on healthcare products. This has led to a rise in demand for OTC pharmaceuticals, as individuals seek to take control of their own health and well-being. Furthermore, the government of Mozambique has been investing in healthcare infrastructure and promoting access to essential medicines. This has created a favorable environment for the growth of the Other OTC Pharmaceuticals (Pharmacies) market, as pharmacies are able to operate more efficiently and effectively in providing healthcare services to the population. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Mozambique is experiencing growth due to customer preferences for convenience and affordability, as well as the increasing demand for preventive healthcare products and natural remedies. The local special circumstances, such as the high burden of infectious diseases and the lack of healthcare infrastructure in rural areas, further contribute to the importance of pharmacies in the country. The underlying macroeconomic factors, including a growing middle class and government investments in healthcare, are driving the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)